Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
Adjuvanted SARS-CoV-2 Spike protein Potential treatment - pre-clinical evidence Experimental Vaccine Apr/01/2021 4 0
Canakinumab Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/19/2021 4 0
Estradiol Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/19/2021 1 0
[3-(5-methoxy-2-hydroxy benzylidene amino)-2(5-methoxy-2-hydroxyphenyl)-2,3-dihydro quinazoline-4(1H)-one] Potential treatment - pre-clinical evidence Experimental Antiviral Jan/19/2021 1 0
Ibuprofen Potential treatment - theoretical effect Used to treat other disease Antiviral Jan/18/2021 1 0
Quercetagetin Potential treatment - theoretical effect Natural product Antiviral Jan/12/2021 2 0
4-(3-Phenylacryloyloxymethyl)-6,7-dimethoxycoumarin Potential treatment - theoretical effect Natural product Antiviral Jan/12/2021 1 0
Orientin Potential treatment - theoretical effect Natural product Antiviral Jan/11/2021 1 0
Excel (.xslx) CSV (.csv)